H.R.2148: Prescription Drug Price Relief Act of 2021

About This Bill

Bill Sponsor

Bill Version

Bill Summary

Prescription Drug Price Relief Act of 2021 This bill establishes a series of oversight and disclosure requirements relating to the prices of brand-name drugs. Specifically, the bill requires the Department of Health and Human Services (HHS) to review at least annually all brand-name drugs for excessive pricing; HHS must also review prices upon petition. If any such drugs are found to be excessively priced, HHS must (1) void any...

(Source: Library of Congress)

Bill Actions

Date Description
Oct. 19, 2021
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
March 24, 2021
Referred to the Subcommittee on Health.
March 23, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
March 23, 2021

Introduced in the House by Ro Khanna (D-Calif.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page